Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
Oncology Reviews（2023）
摘要
OPINION Oncol Rev., 20 September 2023 https://doi.org/10.3389/or.2023.11471
更多查看译文
关键词
therapeutic targeting,biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要